Business Context and Reporting Period
This Form 8-K was filed by Lucid Diagnostics Inc. on January 7, 2022, reporting events occurring on January 6, 2022. The company is an emerging growth company incorporated in Delaware with its principal executive offices in New York. The filing primarily serves as a Regulation FD disclosure regarding an upcoming investor event.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance data.
Material Changes
No material changes to financial position or operations are reported in this document. The filing announces a scheduled corporate event rather than a change in business status.
Guidance, Outlook, and Management Commentary
On January 6, 2022, the Company announced that Lishan Aklog, Chairman and Chief Executive Officer, will participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference. The event is scheduled for January 11, 2022, at 11:30 AM EST. The press release detailing this event is attached as Exhibit 99.1. The filing explicitly states that the information furnished is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Important Facts for Investors to Verify
- Confirm the date and time of the Fireside Chat (January 11, 2022, 11:30 AM EST) to access management commentary.
- Review the attached press release (Exhibit 99.1) for any specific strategic updates or guidance provided by the CEO.
- Note that this filing does not contain audited financial data; refer to the most recent 10-K or 10-Q for financial metrics.
- Verify the company's status as an emerging growth company, which may impact financial reporting requirements.